Pembrolizumab Intravenous Solution Priced at $339.65 at Aurora Sheboygan
Overview: Pembrolizumab is an intravenous immunotherapy medication used to treat various cancers, such as melanoma, non-small cell lung cancer, head and neck cancer, and certain lymphomas. At Aurora Medical Center Sheboygan County, the fee for a 100 mg/4 ml IV solution is $339.65. This price typically covers only the medication itself and does not include additional charges such as infusion administration, facility fees, or related laboratory work. Patients should request a detailed, itemized estimate from the provider to clarify which services are included and anticipate the full scope of costs associated with Pembrolizumab treatment.
Cost Breakdown
- Pembrolizumab medication (100 mg/4 ml): $339.65
- Infusion administration fee: Often billed separately; verify with provider
- Facility/clinic fees: Additional charges may apply per visit
- Pre-infusion labs and monitoring: Usually billed separately
- Follow-up appointments: Additional costs for ongoing assessment
Associated Costs
- Pre-treatment blood tests and imaging
- Physician consultation fees
- Medications to manage side effects
- Possible hospitalization if serious side effects occur
Insurance & Payment Advice
- Verify insurance coverage for Pembrolizumab and associated services before starting treatment
- Ask about prior authorization requirements and any out-of-pocket responsibilities
- Request a comprehensive cost estimate, including drug, infusion, and facility fees
- Explore patient assistance programs or manufacturer copay cards if costs are a concern
Side Effect & Recovery Considerations
- Common side effects: fatigue, rash, itching, diarrhea
- Serious side effects: immune-related reactions affecting organs such as the lungs, liver, or thyroid
- Monitor for symptoms and report any unusual reactions promptly
- Some side effects may require additional medical management, impacting overall costs and recovery
Frequently Asked Questions
- What is Pembrolizumab and how does it work?
- Pembrolizumab is an immunotherapy drug that helps the immune system recognize and attack cancer cells by blocking the PD-1 protein.
- What cancers can Pembrolizumab treat?
- It is used for melanoma, non-small cell lung cancer, head and neck cancer, and certain types of lymphoma, among others.
- How is Pembrolizumab administered?
- Pembrolizumab is given as an intravenous infusion in a healthcare setting under professional supervision.
- Does the listed price include all treatment costs?
- No, the $339.65 fee covers only the medication. Additional charges for infusion, facility use, and other services are common.
- Will insurance cover Pembrolizumab?
- Coverage varies. Always check with your insurer regarding prior authorization, coverage limits, and out-of-pocket costs.
- What are the common side effects of Pembrolizumab?
- Fatigue, rash, itching, and diarrhea are common. Serious immune reactions can also occur and should be reported immediately.
- Are there financial assistance options?
- Yes, patient assistance programs and manufacturer support may help offset costs. Ask the provider or pharmacy for resources.
- How often is Pembrolizumab given?
- The infusion schedule varies by diagnosis but is typically every 3 or 6 weeks. Your oncologist will provide a specific plan.
- What should I do if I experience side effects?
- Contact your healthcare team promptly, especially for serious or unusual symptoms. Some side effects require urgent medical attention.
- Can I get an itemized estimate for my treatment?
- Yes, you should request an itemized estimate from your provider outlining all expected costs.
- Are additional lab tests needed before or during treatment?
- Yes, regular lab tests and monitoring are often required to ensure safety and effectiveness during Pembrolizumab therapy.
Pembrolizumab, available at Aurora Medical Center Sheboygan County, is an intravenous immunotherapy solution used primarily in the treatment of various types of cancer, including melanoma, non-small cell lung cancer, and others. This medication works by blocking a protein called PD-1, which helps the immune system detect and fight cancer cells more effectively. At Aurora Sheboygan, the price for Pembrolizumab 100 mg/4 ml IV solution is $339.65, reflecting the cost of this advanced cancer treatment option.
What is Pembrolizumab and how does it work? – Pembrolizumab is an immunotherapy drug that enhances the body’s immune response against cancer cells by inhibiting the PD-1 protein, allowing T-cells to better identify and attack tumors.
What types of cancer can Pembrolizumab treat? – Pembrolizumab is used to treat several types of cancer, including melanoma, non-small cell lung cancer, head and neck cancer, and certain types of lymphoma, among others.
How is Pembrolizumab administered? – Pembrolizumab is administered as an intravenous infusion, typically given in a healthcare setting under the supervision of medical professionals.
What are the potential side effects of Pembrolizumab? – Common side effects include fatigue, rash, itching, and diarrhea, while more serious effects can involve inflammation of organs such as the lungs, liver, or colon, requiring immediate medical attention.
How often is Pembrolizumab treatment given? – The frequency of Pembrolizumab infusions varies based on the specific cancer being treated and the patient’s response, but it is generally administered every three to six weeks.
Is Pembrolizumab covered by insurance? – Coverage for Pembrolizumab can vary depending on the patient’s insurance plan, so it is important to consult with the insurance provider to understand the specifics of coverage and potential out-of-pocket costs.
What should patients discuss with their doctor before starting Pembrolizumab? – Patients should inform their doctor about any existing health conditions, ongoing medications, and any history of autoimmune diseases, as these factors can influence the suitability and safety of Pembrolizumab treatment.
